(1)
Use of Levosimendan Versus Dobutamine When Inotropic Support Is Needed in Patients With Severe Acute Decompensated Chronic Heart Failure. UJC 2021, 27 (6), 47-60. https://doi.org/10.31928/1608-635X-2020.6.4760.